TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

1.492 Sohail MR et al. Management and outcome of permanent pacemaker and implantable cardioverterdefibrillator
infections. J Am Coll Cardiol 2007;49:1851-9.
1.493 Sohail MR et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator
infection. Mayo Clin Proc 2008;83:46-53.
1.494 Sopeña B et al. Individualized management of bacteraemia in patients with a permanent endocardial
pacemaker. Clin Microbiol Infect 2010;16:274-80.
1.495 Aslam S et al. Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect
Dis 2010;50:664-71.
1.496 Simon D et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis
2005;40:1108-15.
1.497 Gordon RJ et al. Ventricular assist device-related infections. Lancet Infect Dis 2006;6:426-37.
1.498 American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC
/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006;
114:e84-132.
1.499 Aksoy O et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin
Infect Dis 2007;44:364-72.
1.500 Dickerman SA et al. The relationship between the initiation of antimicrobial therapy and the incidence
of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS). Am
Heart J 2007;154:1086-94.
1.501 Muñoz P et al. Heart valves should not be routinely cultured. J Clin Microbiol 2008;46:2897-901.
1.502 Morris AJ et al. Bacteriological outcome after valve surgery for active infective endocarditis: implications
for duration of treatment after surgery. Clin Infect Dis 2005;41:187-94.
1.503 Buchholtz K et al. Severity of gentamicin‘s nephrotoxic effect on patients with infective endocarditis: a
prospective observational cohort study of 373 patients. Clin Infect Dis 2009;48:65-71.
1.504 Frippiat F et al. Gentamicin in infective endocarditis: how to use it? Clin Infect Dis 2009;49:320-1.
1.505 Buchholtz K et al. Gentamicin in infective endocarditis: how to use it? Clin Infect Dis 2009;49:321-2.
1.506 Baddour LM et al. Infective endocarditis: diagnosis, antimicrobial therapy and management of complications.
Circulation 2005;111:e394-433.
1.507 Nishimura RA et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on
infective endocarditis: a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society
for Cardiovascular Angiography and Interventions and Society of Thoracic Surgeons. Circulation
2008;118:887-96.
1.508 Nishimura RA et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on
infective endocarditis: a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society
for Cardiovascular Angiography and Interventions and Society of Thoracic Surgeons. J Am Coll
Cardiol 2008;52:676-85.
1.509 Habib G et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new
version 2009) by the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis
of the European Society of Cardiology (ESC) endorsed by the European Society of Clinical Microbiology
and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy
(ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
1.510 Elliott TS al. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working
Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004;54:971-
81.
1.511 Hill EE et al. Evolving trends in infective endocarditis. Clin Microbiol Infect 2006;12:5-12.
1.512 Mylonakis E et al. Infective endocarditis in adults. N Engl J Med 2001;345:1318-1330.
1.513 Moreillon P et al. Infective endocarditis. Lancet 2004;363:139-49.
1.514 Beynon RP et al. Infective endocarditis. Br Med J 2006;333:334-9.
1.515 Paterick TE et al. Complexity and subtlety of infective endocarditis. Mayo Clin Proc 2007;82:615-21.
1.516 Tak T et al. Current diagnosis and treatment of infective endocarditis. Expert Rev Anti Infect Ther
2003;1:639-54.
1.517 Le T et al. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 2003;36:615-21.
1.518 Fenollar F et al. Whipple‘s endocarditis: review of the literature and comparisons with Q fever, Bartonella
infection, and blood culture-positive endocarditis. Clin Infect Dis 2001;33:1309-16.
1.519 Houpikian P et al. Blood culture-negative endocarditis in a reference center. Etiologic diagnosis of
348 cases. Medicine 2005;84:162-73.
1.520 Brouqui P et al. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-
207.
1.521 Fournier PE et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective
study of 819 new cases. Clin Infect Dis 2010;51:131-40.
1.522 Brouqui P et al. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-
207.
1.523 Miro JM et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from
the International Collaboration on Endocarditis merged database. Clin Infect Dis 2005;41:507-14.
1.524 Millar BC et al. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.
J Antimicrob Chemother 2008;61:1-7.
1.525 Chu VH et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.
Clin Infect Dis 2008;46:232-42.
1.526 Knoll B et al. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect
Dis 2007;44:1585-92.
1.527 Falagas ME et al. Linezolid for the treatment of patients with endocarditis: a systematic review of the
published evidence. J Antimicrob Chemother 2006;58:273-80.
1.528 Muñoz P et al. Linezolid therapy for infective endocarditis. Clin Microbiol Infect 2007;13:211-5.
1.529 Beck M et al. Comprehensive study of strains previously designated Streptococcus bovis consecutively
isolated from human blood cultures and emended description of Streptococcus gallolyticus and
Streptococcus infantarius subsp. coli. J Clin Microbiol 2008;46:2966-72.
1.530 Beck M et al. Comprehensive study of strains previously designated Streptococcus bovis consecutively
isolated from human blood cultures and emended description of Streptococcus gallolyticus and
Streptococcus infantarius subsp. coli. J Clin Microbiol 2008;46:2966-72.
1.531 Gavaldà J et al. Treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann
Intern Med 2007;146:574-9.